Latest News & Updates
Breaking News
3 hours ago
Pharma Now Editorial Team
Roche Pipeline Advances Signal Scale-Up Pressure for CMOs
Pharma Now Editorial Team
Sanofi's Five Q1 Approvals Signal GMP Capacity Pressure Ahead
Pharma Now Editorial Team
Orion Pharma Advances TEAD Inhibitor Into Combination Trials
Pharma Now Editorial Team
FDA's DMF Prior Assessment Process Opens Early Review Window for API Suppliers
Pharma Now Editorial Team
Other trending news you may like to read
Ipsen's Tazverik Exit and Rare Disease Bets Signal Pipeline Pivot
Ipsen withdraws Tazverik on safety signals while rare disease sales surge 125% CER and three Phase III readouts loom in H2 2026.
Pharma Now Editorial Team
Roche Pipeline Advances Signal Scale-Up Pressure for CMOs
Roche Q1 2026 pipeline advances in MS and obesity signal near-term CMO scale-up demands as Phase III data matures.
Pharma Now Editorial Team
Sanofi's Five Q1 Approvals Signal GMP Capacity Pressure Ahead
Sanofi posts five Q1 immunology approvals and 13.6% CER sales growth, raising near-term GMP capacity and compliance demands.
Pharma Now Editorial Team
Orion Pharma Advances TEAD Inhibitor Into Combination Trials
Orion Pharma launches TEADCO basket trial testing ODM-212 across mesothelioma, NSCLC, and pancreatic cancer combination regimens.
Pharma Now Editorial Team
